yohimbine has been researched along with Age-Related Memory Disorders in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Bertoglio, LJ; Franzen, JM; Giachero, M; Marin, FN; Molina, VA; Troyner, F | 1 |
| Banafshe, HR; Jafari-Sabet, M; Khodadadnejad, MA | 1 |
| Nasehi, M; Norozpour, Y; Sabouri-Khanghah, V; Torabi-Nami, M; Zarrindast, MR | 1 |
| Beiranvand, A; Moghaddasi, M; Nasehi, M; Zarrindast, MR | 1 |
| Kindt, M; Soeter, M | 1 |
| Cai, J; Zhang, M | 1 |
| Laurent, B; Poitrenaud, J; Sebban, C | 1 |
| Varkey, S | 1 |
| Borzeix, MG; Cahn, J; Herold, M | 1 |
2 trial(s) available for yohimbine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Stimulation of the noradrenergic system during memory formation impairs extinction learning but not the disruption of reconsolidation.
Topics: Adolescent; Adrenergic alpha-2 Receptor Antagonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Blood Pressure; Conditioning, Classical; Double-Blind Method; Electric Stimulation; Extinction, Psychological; Fear; Female; Galvanic Skin Response; Humans; Male; Memory Disorders; Norepinephrine; Propranolol; Salivary alpha-Amylases; Time Factors; Yohimbine; Young Adult | 2012 |
Memory disorders in 8,037 elderly patients with age-associated memory impairment: multicenter trial with a 6-month follow-up under almitrine-raubasine.
Topics: Aged; Aged, 80 and over; Aging; Almitrine; Drug Combinations; Family Practice; Follow-Up Studies; Humans; Memory Disorders; Middle Aged; Neuroprotective Agents; Secologanin Tryptamine Alkaloids; Yohimbine | 1995 |
7 other study(ies) available for yohimbine and Age-Related Memory Disorders
| Article | Year |
|---|---|
Taking advantage of fear generalization-associated destabilization to attenuate the underlying memory via reconsolidation intervention.
Topics: Adrenergic alpha-Agonists; Animals; CA1 Region, Hippocampal; Clonidine; Early Growth Response Protein 1; Extinction, Psychological; Fear; Generalization, Psychological; Male; Memory; Memory Consolidation; Memory Disorders; Mental Recall; Rats; Rats, Wistar; Sympatholytics; Yohimbine | 2020 |
Modulation of muscimol state-dependent memory by α2-adrenoceptors of the dorsal hippocampal area.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Avoidance Learning; CA1 Region, Hippocampal; Clonidine; GABA-A Receptor Agonists; Male; Memory Disorders; Mice; Muscimol; Receptors, Adrenergic, alpha-2; Yohimbine | 2013 |
The effect of CA1 α2 adrenergic receptors on memory retention deficit induced by total sleep deprivation and the reversal of circadian rhythm in a rat model.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-2 Receptor Antagonists; Animals; Behavior, Animal; CA1 Region, Hippocampal; Circadian Rhythm; Clonidine; Disease Models, Animal; Memory Consolidation; Memory Disorders; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Retention, Psychology; Sleep Deprivation; Yohimbine | 2016 |
Involvement of medial prefrontal cortex alpha-2 adrenoceptors on memory acquisition deficit induced by arachidonylcyclopropylamide, a cannabinoid CB1 receptor agonist, in rats; possible involvement of Ca2+ channels.
Topics: Amnesia; Animals; Arachidonic Acids; Calcium Channels; Clonidine; Dose-Response Relationship, Drug; Imidazoles; Male; Memory; Memory Disorders; Prefrontal Cortex; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Adrenergic, alpha-2; Yohimbine | 2016 |
Extract of Ginkgo biloba leaves reverses yohimbine-induced spatial working memory deficit in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Ginkgo biloba; Male; Memory Disorders; Plant Extracts; Psychomotor Performance; Rats; Rats, Wistar; Reaction Time; Space Perception; Yohimbine | 2005 |
Overdose of yohimbine.
Topics: Adult; Atrial Fibrillation; Body Temperature; Drug Overdose; Humans; Male; Memory Disorders; Yohimbine | 1992 |
[Pharmacology of brain circulation and clinical extrapolations. An experimental study of the circulatory and metabolic effects of Hydrosarpan 711].
Topics: Animals; Brain; Brain Edema; Cerebrovascular Circulation; Cerebrovascular Disorders; Dogs; Drug Combinations; Humans; Intracranial Arteriosclerosis; Memory Disorders; Oxygen Consumption; Piperazines; Rabbits; Yohimbine | 1974 |